A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.

about

Do single-arm trials have a role in drug development plans incorporating randomised trials?Adaptive graph-based multiple testing procedures.Unbiased estimation for response adaptive clinical trials.

P2860

Q36866317-EB2EEA25-82E0-4F5F-AC6E-3704847E7BA4 Q38963322-1146B1A8-29F0-4DBD-9B02-52CCF3F67CC0 Q41490570-E66D3215-2DC4-4527-9B5D-D615489CD5EA

P2860

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.

Item

http://www.wikidata.org/entity/Q38201406

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A review and re-interpretation ...... stimation in two-stage trials.

@en

type

Item

label

A review and re-interpretation ...... stimation in two-stage trials.

@en

prefLabel

A review and re-interpretation ...... stimation in two-stage trials.

@en

P1476

A review and re-interpretation ...... stimation in two-stage trials.

@en

P2093

A Mander

http://www.w3.org/2001/XMLSchema#string

J Bowden

http://www.w3.org/2001/XMLSchema#string

P2860

Two-stage adaptive design for clinical trials with survival data

The reassessment of trial perspectives from interim data--a critical view.

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Do single-arm trials have a role in drug development plans incorporating randomised trials?

Sample size reestimation by Bayesian prediction.

Proper inference from Simon's two-stage designs.

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look.

Mid-course sample size modification in clinical trials based on the observed treatment effect.

Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples' by C. R. Mehta and S. J. Pocock.

P304

163-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PST.1613

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261294252

http://www.w3.org/2001/XMLSchema#string

P698

24692348

http://www.w3.org/2001/XMLSchema#string

P932

4288989

http://www.w3.org/2001/XMLSchema#string

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.

about

P2860

P2860

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932